Population norms of health-related quality of life in Moscow, Russia: the EQ-5D-5L-based survey

被引:27
作者
Holownia-Voloskova, Malwina [1 ,2 ]
Tarbastaev, Aleksei [3 ]
Golicki, Dominik [1 ]
机构
[1] Med Univ Warsaw, Dept Expt & Clin Pharmacol, Banacha 1b St, PL-02097 Warsaw, Poland
[2] State Budgetary Inst, Res Inst Healthcare Org & Med Management, Moscow Healthcare Dept, Hlth Technol Assessment Div, Moscow, Russia
[3] Yury Luzhkov Moscow Metropolitan Governance Univ, Dept Educ Programs Dev, Ctr Hlth & Social Dev, 28 Sretenka St, Moscow 107045, Russia
关键词
Health-related quality of life; Patient-reported outcomes; Normative values; Reference values; EQ-5D; Russia; PSYCHOMETRIC PROPERTIES; NORMATIVE VALUES; EQ-5D-3L; SAMPLE; CHINA;
D O I
10.1007/s11136-020-02705-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose To develop population norms for the EQ-5D-5L questionnaire based on a representative sample of Moscow citizens. Methods We used quota sampling accounting for sex, age group and administrative district of residence. Respondents in randomly selected outdoor and indoor locations were surveyed with the official Russian paper-and-pencil version of the EQ-5D-5L questionnaire and a set of socio-demographic questions. We estimated four types of EQ-5D results: the distribution of limitations according to EQ-5D-5L dimensions, the perception of the health-related quality of life (HRQoL) with a visual analogue scale (EQ VAS), the unweighted score for a respondent's health state (Level Sum Score, LSS) and the Russian health preferences-based weighted score (EQ index). In order to estimate the EQ-5D-5L index, we used a newly developed Russian EQ-5D-3L value set, together with EuroQol Group cross-over methodology. Results A total of 1020 respondents (18-93 years old) from the general Moscow adult population completed the EQ-5D-5L questionnaire. HRQoL domains with the largest number of identified health limitations were pain/discomfort (48.6%) and anxiety/depression (44.1%). Two hundred seventy-nine respondents (27.0%) did not report any health restrictions. The mean EQ VAS and EQ-5D-5L index were 74.1 (SD 17.3) and 0.907 (0.106) respectively. Multivariate analysis showed that female sex, advanced age and lack of access to the Internet had a negative influence on HRQoL, whereas residence in certain districts had a positive impact. Conclusions The study provides population norms of health-related quality of life in Moscow, measured according to the EQ-5D-5L questionnaire. These reference values can be used to optimise the effectiveness of resource allocation in healthcare.
引用
收藏
页码:831 / 840
页数:10
相关论文
共 46 条
[1]  
[Акулова Анна Игоревна Akulova A.I.], 2018, [Научно-практическая ревматология, Rheumatology Science and Practice, Nauchno-prakticheskaya revmatologiya], V56, P351, DOI 10.14412/1995-4484-2018-351-355
[2]  
[Anonymous], 2014, Self-Reported population health: an international perspective based on EQ-5D
[3]  
[Anonymous], 2000, INEQUALITY MORTALITY
[4]   An EQ-5D-5L value set based on Uruguayan population preferences [J].
Augustovski, Federico ;
Rey-Ares, Lucila ;
Irazola, Vilma ;
Garay, Osvaldo Ulises ;
Gianneo, Oscar ;
Fernandez, Graciela ;
Morales, Marcelo ;
Gibbons, Luz ;
Manuel Ramos-Goni, Juan .
QUALITY OF LIFE RESEARCH, 2016, 25 (02) :323-333
[5]   EuroQol: The current state of play [J].
Brooks, R .
HEALTH POLICY, 1996, 37 (01) :53-72
[6]   Health problems are more common, but less severe when measured using newer EQ-5D versions [J].
Craig, Benjamin M. ;
Pickard, A. Simon ;
Lubetkin, Erica I. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2014, 67 (01) :93-99
[7]  
Deyev A I, 2018, Adv Gerontol, V31, P851
[8]   Socioeconomic differences in self-rated health among women: a comparison of St. Petersburg to Estonia and Finland [J].
Dubikaytis, Tatiana ;
Harkanen, Tommi ;
Regushevskaya, Elena ;
Hemminki, Elina ;
Haavio-Mannila, Elina ;
Laanpere, Made ;
Kuznetsova, Olga ;
Koskinen, Seppo .
INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH, 2014, 13
[9]  
EuroQol Research Foundation, 2019, EQ 5D REC TOOL US CO
[10]  
Fayers P., 2005, Assessing quality of life in clinical trials: Methods and practice